Pilon Fracture Reduction and Functional Outcome
Quality of Fracture Reduction and Its Influence on Functional Outcome in Patients With Pilon Fractures - a Prospective Multicenter Case Series
1 other identifier
observational
117
4 countries
9
Brief Summary
This prospective case series will essentially examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation. The plates used in this trial can be chosen according to the preferences of the surgeon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2011
Longer than P75 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2011
CompletedFirst Posted
Study publicly available on registry
March 16, 2011
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedAugust 13, 2020
January 1, 2018
5.2 years
March 14, 2011
August 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Examine the influence of reduction quality on the primary functional outcome (as assessed using the Foot and Ankle Ability Measure (FAAM)) of patients with pilon fractures treated with plate fixation.
The most important predictors of functional outcome after pilon fracture will be identified by evaluating the influence of radiologically assessed parameters of reduction quality and other factors (age, high/low energy trauma, AO fracture type, open/closed fracture, delay between trauma and definitive fracture fixation) on the FAAM. In parallel, the radiological parameters will also be validated with respect to their reliability.
2 years
Secondary Outcomes (3)
Surgical details
1 year
Pre- and postoperative treatment
1 year
To assess whether patient and surgeon expectations are met with regard to the trauma outcome
1 year
Eligibility Criteria
Patients with pilon fractures that fulfill the following inclusion and exclusion criteria
You may qualify if:
- Age 18 years and older
- Patients with a unilateral intraarticular pilon fracture of the distal tibia classified according to AO: AO 43 - B1, B2 and B3 (partial intraarticular) AO 43 - C1, C2 and C3 (total intraarticular)
- Definitive fracture fixation with a plate within 4 weeks after accident (Temporary fixation with an external fixator, cast or traction is allowed)
- Signed written informed consent (by the patients) and agreement to attend the planned FU evaluations
You may not qualify if:
- Contralateral fracture of the distal half of the tibia/fibula/talus
- Pathologic fracture
- Severe Polytrauma: Injury Severity Score (ISS) \> 28
- Preexisting severe vascular disease (chronic venous insufficiency, chronic arterial occlusive disease)
- Drug or alcohol abuse
- American Society of Anesthesiologists (ASA) class V and VI
- Inability to walk independently prior to injury event
- Neurological and psychiatric disorders that would preclude reliable assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Indiana Orthopaedic Hospital
Indianapolis, Indiana, 46202, United States
University of Minnesota
Saint Paul, Minnesota, 55101, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
Harborview Medical Center
Seattle, Washington, 98104, United States
Medical University Innsbruck
Innsbruck, 6020, Austria
Universidade de São Paulo - Faculdade de Medicina
São Paulo, CEP, 05403-010, Brazil
Cantonal Hospital Graubuenden
Chur, 7000, Switzerland
Cantonal Hospital Luzern
Lucerne, 6000, Switzerland
Cantonal Hospital Winterthur
Winterthur, 8401, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Sommer, MD
Cantonal Hospital Graubuenden
- STUDY DIRECTOR
Martin Schuler, PhD
AO Clinical Investigation and Documentation, Davos, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2011
First Posted
March 16, 2011
Study Start
November 1, 2011
Primary Completion
January 1, 2017
Study Completion
March 1, 2017
Last Updated
August 13, 2020
Record last verified: 2018-01